Table 3.
Very important to know | Not enough information | |||
---|---|---|---|---|
Topic | n | (%) | n | % |
Any increased risks for second colorectal cancers, other cancers, and other diseases | 153 | (98) | 122 | (78) |
The schedule of recommended colorectal cancer surveillance | 153 | (98) | 79 | (51) |
Possible signs of recurrence and second tumors | 145 | (93) | 93 | (60) |
The schedule of recommended screenings for non-colorectal cancers | 139 | (89) | 85 | (54) |
Chemoprevention strategies for secondary prevention (e.g., tamoxifen in women at high risk for breast cancer) | 135 | (87) | 112 | (72) |
The possible long-term risks and complications from radiation therapy | 135 | (87) | 104 | (67) |
The possible long-term risks and complications from chemotherapy | 131 | (85) | 114 | (73) |
Other types of follow-up care providers that may be needed (e.g., rehabilitation, fertility, psychology) | 124 | (79) | 111 | (71) |
Genetic counseling and testing to identify high-risk individuals who could benefit from more comprehensive cancer surveillance | 122 | (78) | 129 | (83) |
Possible effects of cancer on marital/partner relationship, sexual functioning, work, parenting, and future needs for psychosocial support | 117 | (75) | 99 | (63) |
Support groups and other resources for colorectal cancer survivors | 100 | (64) | 105 | (67) |
Total number of respondents does not always equal 156 due to missing data.